| Next |
Ad
AGN Message Board | Allergan plc
home / stock / agn / agn message board
Message Board | Allergan plc (NYSE:AGN)
| Subject | By | Source | When |
|---|---|---|---|
| 193.00 Game-Changer: The FDA Approved Eye Drops That | barnyarddog | investorshub | 12/14/2021 6:42:00 AM |
| Please dont invest your grandkids money here. | Builder | investorshub | 06/02/2021 11:47:06 AM |
| It doesn't look to be trading? | Builder | investorshub | 04/06/2021 5:18:02 PM |
| What happened here rcookr1? | Builder | investorshub | 03/19/2021 12:59:37 AM |
| That's a wrap! | DewDiligence | investorshub | 05/08/2020 8:58:23 PM |
| $ABBV completes $65B$ AGN acquisition: | DewDiligence | investorshub | 05/08/2020 8:57:14 PM |
| 1Q20 worldwide Botox sales=$812.2M, -6% YoY, -20% QoQ*: | DewDiligence | investorshub | 05/08/2020 7:00:30 PM |
| $ABBV-AGN merger expected to close 5/8/20: | DewDiligence | investorshub | 05/06/2020 4:48:14 PM |
| Following FTC agreement, $ABBV-AGN plan May 2020 | DewDiligence | investorshub | 03/17/2020 9:31:19 PM |
| $ABBV-AGN receive EU approval for mergerUS FTC approval | DewDiligence | investorshub | 03/03/2020 2:31:48 PM |
| 4Q19 worldwide Botox sales=$1.020B, +8% YoY, +10% QoQ*: | DewDiligence | investorshub | 02/10/2020 5:48:22 PM |
| FDA approves $AGNs Ubrelvy (ubrogepant) for acute migraine treatment: | DewDiligence | investorshub | 12/23/2019 8:23:55 PM |
| 3Q19 worldwide Botox sales=$928.7M, +6% YoY, -5% QoQ*: | DewDiligence | investorshub | 11/05/2019 3:11:51 PM |
| 2Q19 worldwide Botox sales=$974.0M, +4% YoY, +12% QoQ*: | DewDiligence | investorshub | 08/06/2019 11:58:18 AM |
| agn looking to buy $EYEN. still a | jdlamont | investorshub | 06/25/2019 3:28:58 PM |
| LOL. These lawsuit PRs are pre-written fill-in-the-blanks forms | DewDiligence | investorshub | 06/25/2019 3:04:08 PM |
| News: $AGN Allergan Merger Investigation: Halper Sadeh LLP | whytestocks | investorshub | 06/25/2019 2:50:25 PM |
| $ABBV-AGN CC slides: | DewDiligence | investorshub | 06/25/2019 2:02:47 PM |
| News: $AGN AbbVie to Acquire Allergan in Transformative | whytestocks | investorshub | 06/25/2019 1:50:30 PM |
| RF-frequency devices for aesthetic applications go back at | DewDiligence | investorshub | 06/24/2019 6:41:34 PM |
Stock Information
Get AGN Alerts
News, Short Squeeze, Breakout and More Instantly...
Allergan plc Company Name:
AGN Stock Symbol:
NYSE Market:
0.02% G/L:
$193.02 Last:
10,732,573 Volume:
$193.01 Open:
$193.02 Close:
Allergan plc Website:
Ad
-
2024-03-27 17:08:02 ET About to begin a phase 2b/3 multinational study of Ifenprodil Algernon Pharmaceuticals is a drug repurposing company. They're a phase 2 clinical stage company advancing a drug called Ifenprodil for idiopathic pulmonary fibrosis, but also as a potential thera...
-
2024-03-27 17:08:02 ET A stroke can be a devastating and debilitating event for an individual and their family, and a major burden on the health care system. Over 15 million people suffer strokes every year, and 85% of those have some form of disability as a result. Stroke-related cos...
-
2024-03-27 17:08:02 ET Stocks to Invest in: Healthcare Focused on the disease areas of stroke, idiopathic pulmonary fibrosis (IPF) & chronic cough, and chronic kidney disease Algernon is a drug re-purposing company that investigates safe, already approved drugs, inclu...